Depakote Birth Defects Lawsuit

Depakote birth defects lawsuit is filed by a woman who claims that her daughter suffered from Depakote birth defects when she was pregnant. According to the claim, the chemical in Depakote birth defects caused her fetus to be deformed and eventually died. Her case is filed against Triton Laboratories, a major producer of Depakote.

The woman is seeking compensation for the loss of her daughter. A hearing has been set for July 12 in a federal court in Phoenix. The lawsuit claims damages for pain and suffering, medical expenses and disability benefits.

Depakote Birth Defects Lawsuit

The lawsuit claims that Triton created an extremely dangerous product when it created Depakote. The defect in Depakote birth defect came about when the drug was mixed with a compound called “Aminophthalate”. Aminophthalate is known to cause brain damage in unborn fetuses.

Triton failed to warn the FDA or the courts that the drug was potentially dangerous, which allowed the drug to be used as of the date of conception without warning the defects would occur.

Illinois is one of twenty states that allow off-label depakote use.

Illinois law allows any member of the class to file a personal injury lawsuit for pain and suffering and other benefits. Some of the plaintiffs in the depakote class action lawsuit were unable to work outside of their home due to the effects of the defect. Other plaintiffs have lost their jobs or suffered an income decrease because of the effects of the defect.

The complaint in the depakote birth defects lawsuit asserts negligence on behalf of Triton and other defendants.

It is alleged that Triton failed to conduct research concerning bifidism and to warn the public of the potential risks of using depakote. It is also claimed that Triton did not warn of the risks of its use with infants and did not instruct physicians regarding the drug’s possible defectiveness. One plaintiff additionally claims that Triton engaged in numerous deceptive practices in an effort to conceal the risks associated with its use with infants.

Plaintiffs claim that they were exposed to an unsafe amount of the drug when taking depakote.

During their pregnancy, the plaintiffs sustained injuries including low blood pressure, preeclampsia, and dystocia. The injuries progressed and required additional care until the full-term birth of one child. The injury plaintiffs say they would have been prevented from suffering these ailments if they had only known about the risks of taking depakote. Also, other plaintiffs say they only learned of the dangers of taking depakote when their children developed acute respiratory distress after consuming large amounts of it during pregnancy.

A representative from the company will be available for a free consultation.

During this time, the plaintiff and his or her attorney will discuss the merits of the case. If there is sufficient evidence to move forward with the lawsuit, a settlement offer will be made. This process has worked well for many plaintiffs, as it allows them the chance to get their justice through the courts without the help of money lenders. If you or someone you know is pregnant, nursing or past due, it is important to speak with an attorney about a free consultation and the possibility of a lawsuit against GlaxoSmithKline.